India's regulatory authority, the Central Drugs Standard Control Organization, has not had a particularly good start to 2012. Accounts of corruption and incompetence have been echoed in numerous reports, and now a panel of experts is set to dig further into the agency in the hopes of recommending needed reforms. The list of purported deficiencies at the agency has grown substantially in recent months. The agency has been accused at various times of exercising lax clinic...

Fallout from a report by the Indian Parliament alleging widespread collusion and ineffectiveness at India's Central Drugs Standard Control Organization (CDSCO) continues, as the Indian government has launched a formal inquiry into the allegations, reports Reuters . "The government said in a statement that it had appointed three experts to look at the scientific basis for approving new drugs without clinical trials and to recommend ways of overhauling the approval proced...

A parliamentary report authored by India's Standing Committee on Health and Family Welfare (SCHFW) is blasting the country's Central Drugs Standard Control Organisation (CDSCO), India's drug regulatory authority, calling it a "collusive nexus" between industry, government and medical experts, reports Reuters . The report follows an account published in April 2012 by The Times of India , which reported CDSCO's Drug Controller General of India (DCGI), which oversees su...